BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
Franklin Lakes-based BD (Becton, Dickinson and Co.) on June 8 announced it received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination ...
BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
Medical Device Network on MSN
BD and Ypsomed develop new version of Neopak XtraFlow syringe
The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.
Researchers will highlight new injection systems, wearable devices and testing services supporting high-viscosity biologics, ...
The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
When BD unveiled a four-year, $1.2 billion upgrade to its drug delivery device manufacturing last year, the company teased plans for a new factory in Europe—and now it’s showing its hand. BD has ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
FRANKLIN LAKES, N.J., June 8, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results